Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;27(6):836-847.
doi: 10.5603/CJ.a2018.0120. Epub 2018 Oct 19.

Cardiovascular complications after radiotherapy

Affiliations
Review

Cardiovascular complications after radiotherapy

Izabela Nabiałek-Trojanowska et al. Cardiol J. 2020.

Abstract

Over the past decades, effective cancer therapies have resulted in a significant improvement in the survival rates for a number of cancers and an increase in the number of cancer survivors. Radiation therapy is widely used in the treatment of cancer, and it can induce various cardiotoxicities that differ considerably from chemotherapy-induced cardiotoxicity. They occur primarily as late radiation-induced complications, several years from the end of anticancer treatment and present as coronary artery disease, heart failure, pericardial disease, valvular heart disease and arrhythmias. Patients who recovered from cancer disease suffer from cardiac complications of anticancer treatment, it affects the quality of their lives and life expectancy, especially if the diagnosis is delayed. These patients may present distinct symptoms of cardiac injury, resulting from radiation-induced neurotoxicity and altered pain perception, which makes diagnosis difficult. This review highlights the need for a screening programme for patients who have undergone radiation therapy and which will subsequently have a potentially profound impact on morbidity and mortality.

Keywords: cardiotoxicity; ionizing radiation; neoplasms; radiation injuries; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

References

    1. Gustavsson A, Osterman B, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in non-Hodgkin’s lymphoma. Acta Oncol (Madr) 2003;42(5–6):605–619. - PubMed
    1. Di Mattéo J, Vacheron A, Heulin A, et al. [Cardiac complications of thoracic radiotherapy]. Arch Mal Coeur Vaiss. 1978;71(4):447–452. - PubMed
    1. Vacheron A, Heulin A, Baubion N, et al. Cardiac complications of radiotherapy. Ann Cardiol Angeiol (Paris) [Internet. 1983;32(7):465–472. - PubMed
    1. Cuzick J, Stewart HJ, Peto R, et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Clinical Trials. 1987;71(1):7–14. - PubMed
    1. Toltz A, Shin N, Mitrou E, et al. Late radiation toxicity in Hodgkin lymphoma patients: proton therapy’s potential. J Appl Clin Med Phys. 2015;16(5):167–178. doi: 10.1120/jacmp.v16i5.5386. - DOI - PMC - PubMed